Table 6.
Descriptive Statistics of Minimum Inhibitory Concentrations (μg/mL) for S. aureus/Methicillin-Susceptible Isolates of Chronic Conjunctivitis to 9 Antibiotics
S. aureus-MS n=25 |
|
|
|
|
|
|
---|---|---|---|---|---|---|
Antibiotics | Median | MIC50 | MIC90 | Mode | Min MIC to max MIC | % Susceptibility |
Cephalothin | 0.75 | 0.75 | 4.0 | 1.0 | 0.023 to 8 | 100 |
Cefoxitin | 3.0 | 3.0 | 6.0 | 6.0 | 0.19 to 6.0 | 96 |
Ciprofloxacin | 0.19 | 0.19 | 0.5 | 0.38 | 0.025 to 0.75 | 100 |
Clindamycin | 0.094 | 0.094 | 0.47 | 0.125 | 0.016 to >256 | 92 |
Erythromycin | 0.194 | 0.194 | 0.38 | 0.125 | 0.023 to >256 | 84 |
Moxifloxacin | 0.047 | 0.047 | 0.064 | 0.047 | 0.008 to 0.064 | 100 |
Oxacillin | 0.50 | 0.50 | 1.0 | 0.50 | 0.064 to 1.0 | 100 |
Tobramycin | 0.75 | 0.75 | 3 | 1 | 0.25 to 48 | 96 |
Vancomycin | 1.5 | 1.5 | 1.5 | 1.5 | 0.38 to 2.0 | 100 |
MIC, minimum inhibitory concentration.